Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunocore Holdings plc

29.81
-0.6200-2.04%
Post-market: 29.810.00000.00%16:55 EDT
Volume:440.01K
Turnover:13.29M
Market Cap:1.49B
PE:-29.17
High:30.97
Open:30.02
Low:29.22
Close:30.43
Loading ...

AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe

Zacks
·
18 Nov 2024

Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?

Insider Monkey
·
18 Nov 2024

Mizuho Securities Downgrades Immunocore to Neutral From Outperform, $72 Price Target

MT Newswires Live
·
11 Nov 2024

Immunocore Holdings Cut to Neutral From Outperform by Mizuho

Dow Jones
·
11 Nov 2024

Immunocore : Mizuho Cuts Target Price to $38 From $72

THOMSON REUTERS
·
11 Nov 2024

Immunocore Holdings Prepares Early Loan Agreement Termination

TIPRANKS
·
09 Nov 2024

Oppenheimer Trims Immunocore Price Target to $88 From $89, Maintains Outperform Rating

MT Newswires Live
·
07 Nov 2024

Morgan Stanley Remains a Buy on Immunocore Holdings (IMCR)

TIPRANKS
·
07 Nov 2024

Immunocore Holdings Is Maintained at Buy by Needham

Dow Jones
·
07 Nov 2024

Barclays Keeps Their Buy Rating on Immunocore Holdings (IMCR)

TIPRANKS
·
07 Nov 2024

Buy Rating Affirmed for Immunocore Holdings Amid Strong Q3 Performance and Revised Revenue Forecasts

TIPRANKS
·
07 Nov 2024

Immunocore : TD Cowen Cuts Target Price to $60 From $90

THOMSON REUTERS
·
06 Nov 2024

Immunocore Holdings: Strong Market Performance and Promising Pipeline Drive Buy Rating

TIPRANKS
·
06 Nov 2024

BRIEF-Immunocore Reports Q3 Financial Results And Provides Business Update

Reuters
·
06 Nov 2024

Immunocore Hldgs Q3 2024 GAAP EPS $0.17 May Not Be Comparable To $(0.35) Estimate, Sales $80.25M Miss $80.60M Estimate

Benzinga
·
06 Nov 2024

Immunocore : Plans to Use Existing Cash to Repay Its $50 Mln Loan by End of 2024

THOMSON REUTERS
·
06 Nov 2024